IMMUNOTERAPIYa INFEKІІIONNO-VOSPALITEL'N'ІKh ZABOLEVANIY MOChEVYVODYaShchIKh PUTEY I EE EFFEKTIVNOST'
- Autores: Shevyakov M.A.1
-
Afiliações:
- Edição: Nº 2 (2013)
- Páginas: 98-102
- Seção: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/279749
- ID: 279749
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Texto integral
Bibliografia
- Кульчавеня Е.В. Трудности диагностики туберкулеза мочеполовой системы. Новосибирск, 2004.
- Рафальский В.В., Страчунский Л.С., Кречикова О.И. и др. Резистентность возбудителей амбулаторных инфекций мочевыводящих путей по данным многоцентровыіх микробиологических исследований UTIAP—I и UTIAP—II. Урология. 2004;2:14—17.
- Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002;113(Suppl. 1A):5S—13S.
- Naber K.G., Schito G., Botto H. et al. Surveillance study in Europe and Brazil on clinical aspects and antimicrobial resistance epidemiology in females with cystitis (ARESC): implications for empiric therapy. Eur Urol. 2008;54:1164—1178.
- Hooton T.M., Scholes D., Hughes J.P. et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med. 1996;335:468—474.
- Wagenlehner F.M., Weidner W., Naber K.G. Emerging drugs for bacterial urinary tract infections. Expert Opin Emerg Drugs. 2005;10:275—298.
- Grabe M., Bishop M.C., Bjerklund-Johansen T.E. et al. Guidelines on urological infections. European Association of Urology Web site.
- Raz R., Stamm W.E. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med. 1993;329:753—756.
- Raz R., Chazan B., Kennes Y. et al. Empiric use of trimethoprimsulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens. Clin Infect Dis. 2002;34:1165—1169.
- Albert X., Huertas I., Pereirô II. et al. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev 2004:CD001209.
- Reid G. Probiotic therapy and functional foods for prevention of urinary tract infections: state of the art and science. Curr Infect Dis Rep. 2000;2:518—522.
- Fünfstück R., Straube E., Schildbach O. et al. Prevention of reinfection by L-methionine in patients with recurrent urinary tract infection. Med Klin (Munich). 1997;92:574—581.
- Avorn J., Monane M., Gurwitz JH. et al. Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA. 1994;271:751—754.
- Jepson R.G., Mihaljevic L., Craig J. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2004:CD001321.
- Bessler W.G., Puce K., vor dem Esche U. et al. Immunomodulating effects of OM-89, a bacterial extract from Escherichia coli, in murine and human leukocytes. Arzneimittelforschung/Drug Research. In press.
- Schmidhammer S., Ramoner R., Höltl L. et al. An Escherichia coli-based oral vaccine against urinary tract infections potently activates human dendritic cells. Urology. 2002;60:521—526.
- Van Pham T., Kreis B., Corradin-Betz S. et al. Metabolic and functional stimulation of lymphocytes and macrophages by an Escherichia coli extract (OM-89): in vitro studies. J Biol Response Mod. 1990;9:231—240.
- Marchant A., Duchow J., Goldman M. Adhesion molecules in antibacterial defenses: effects of bacterial extracts. Respiration. 1992;59(Suppl. 3):24—27.
- Chiavaroli C., Moore A. An hypothesis to link the opposing immunological effects induced by the bacterial lysate OM-89 in urinary tract infection and rheumatoid arthritis. BioDrugs. 2006;20:141—149.
- Huber M., Krauter K., Winkelmann G. et al. Immunostimulation by bacterial components: II. Efficacy studies and meta-analysis of the bacterial extract OM-89. Int J Immunopharmacol. 2000; 22:1103—1111.
- Huber M., Baier W., Serr A. et al. Immunogenicity of an E. coli extract after oral or intraperitoneal administration: induction of antibodies against pathogenic bacterial strains. Int J Immunopharmacol. 2000;22:57—68.
- Lee S.J., Kim S.W., Cho Y.H. et al. Anti-inflammatory effect of an Escherichia coli extract in a mouse model of lipopolysaccharide-induced cystitis. World J Urol. 2006;24:33—38.
- Bauer H.W., Alloussi S., Egger G. et al. on behalf of Multicenter UTI Study Group. A long-term, multicenter, double-blind study of an Escherichia coli extract (OM-89) in female patients with recurrent urinary tract infections. Eur Urol. 2005;47:542—548.
- Hachen H.J. Oral immunotherapy in paraplegic patients with chronic urinary tract infections: a double-blind, placebo-controlled trial. J Urol. 1990;143:759—762.
- Lettgen B. Prevention of recurrent urinary tract infections in female children: OM-89 immunotherapy compared with nitrofurantoin prophylaxis in a randomized pilot study. Curr Ther Res. 1996;57:464—475.
- Naber K.G., Cho Y.H., Matsumoto T. et al. Immunoactive prophylaxis ofrecurrent urinary tract infections: a meta-analysis. Int J Antimicrob Agents. 2009;33:111—119.
- Magasi P., Pânovics J., Illés A. et al. Uro-Vaxom and the management of recurrent urinary tract infection in adults: a randomized multicenter double-blind trial. Eur Urol. 1994;26:137—140.
- Baertschi R., Balmer J.A., Eduah S.B. et al. Bacterial extract for the prevention of recurrent urinary tract infections in pregnant women: a pilot study. Int J Immunother. 2003;19:25—31.
- Tammen H. Immunobiotherapy with Uro-Vaxom in recurrent urinary tract infection. The German Urinary Tract Infection Study Group. Br J Urol. 1990;65:6—9.
- Pisani E., Palla R., Bono A.V. Double-blind randomised clinical study of OM-8930 vs placebo in patients suffering from recurrent urinary tract infections [quoted by Chiavaroli C, Moore A. An hypothesis to link the opposing immunological effects induced by the bacterial lysate OM-89 in urinary tract infection and rheumatoid arthritis. BioDrugs 2006; 20:141—9]. Geneva, Switzerland: OM PHARMA; 1992.
- Schulman C.C., Corbusier A., Michiels H. et al. Oral immunotherapy of recurrent urinary tract infections: a double-blind placebocontrolled multicenter study. J Urol. 1993;150:917—921.
- Zenewicz L.A. et al. Trends in Molecular Medicine 2009;5:199—207.
Arquivos suplementares
